Paul J Fletcher

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Alcohol Use Disorder

Tyrosine Kinase

Obsessive Compulsive Disorder

Top Venues

Addiction biology

Science signaling

Centre for Addiction and Mental Health

University of Leeds (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre for Addiction and Mental Health

Canada

Senior Scientist

Education History

University of Leeds

United Kingdom

BSC :: psychology

Publications

Rayane I Tabbara, Zhaoxia Li, Paul J Fletcher, Anh D Lê
The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking. Addiction biology 26 (5) (2021)
Ping Su, Terence K Y Lai, Frankie H F Lee, Andrew R Abela, Paul J Fletcher, Fang Liu
Disruption of SynGAP-dopamine D1 receptor complexes alters actin and microtubule dynamics and impairs GABAergic interneuron migration. Science signaling 12 (593) (2019)
Paul J Fletcher, Zhaoxia Li, Leo B Silenieks, Cam MacMillan, Ines DeLannoy, Guy A Higgins
Preclinical evidence for combining the 5-HT2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependence. Addiction biology 24 (3) (2018)
Andrew R Abela, Zhaoxia Li, Anh D Lê, Paul J Fletcher
Clozapine reduces nicotine self-administration, blunts reinstatement of nicotine-seeking but increases responding for food. Addiction biology 24 (4) (2018)